PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,533,000 | +3.6% | 486,929 | -4.2% | 0.00% | – |
| Q2 2020 | $1,480,000 | +3.0% | 508,504 | -0.2% | 0.00% | – |
| Q1 2020 | $1,437,000 | -20.6% | 509,563 | -8.6% | 0.00% | – |
| Q4 2019 | $1,809,000 | +41.5% | 557,360 | -5.8% | 0.00% | – |
| Q3 2019 | $1,278,000 | -38.1% | 591,741 | -10.0% | 0.00% | -100.0% |
| Q2 2019 | $2,066,000 | -23.1% | 657,796 | -8.9% | 0.00% | 0.0% |
| Q1 2019 | $2,686,000 | +28.1% | 721,994 | -0.2% | 0.00% | 0.0% |
| Q4 2018 | $2,097,000 | -39.5% | 723,114 | -45.2% | 0.00% | 0.0% |
| Q3 2018 | $3,468,000 | +15.5% | 1,318,645 | +2.8% | 0.00% | 0.0% |
| Q2 2018 | $3,002,000 | -19.9% | 1,283,028 | +0.6% | 0.00% | 0.0% |
| Q1 2018 | $3,748,000 | +6.4% | 1,274,992 | -0.8% | 0.00% | 0.0% |
| Q4 2017 | $3,522,000 | -50.4% | 1,285,346 | -38.6% | 0.00% | -50.0% |
| Q3 2017 | $7,097,000 | +35.4% | 2,093,321 | -1.3% | 0.00% | +100.0% |
| Q2 2017 | $5,241,000 | +8.5% | 2,121,872 | -0.3% | 0.00% | 0.0% |
| Q1 2017 | $4,830,000 | +14.3% | 2,127,651 | +6.8% | 0.00% | 0.0% |
| Q4 2016 | $4,224,000 | -19.1% | 1,992,265 | +27.9% | 0.00% | -50.0% |
| Q3 2016 | $5,219,000 | -54.0% | 1,557,964 | -56.9% | 0.00% | -33.3% |
| Q2 2016 | $11,357,000 | +0.1% | 3,616,878 | +6.2% | 0.00% | 0.0% |
| Q1 2016 | $11,346,000 | -4.4% | 3,407,024 | +1.6% | 0.00% | -25.0% |
| Q4 2015 | $11,873,000 | -14.0% | 3,353,903 | +22.2% | 0.00% | 0.0% |
| Q3 2015 | $13,810,000 | -26.7% | 2,745,427 | -6.3% | 0.00% | -20.0% |
| Q2 2015 | $18,836,000 | -4.4% | 2,929,430 | +4.6% | 0.01% | 0.0% |
| Q1 2015 | $19,709,000 | -83.4% | 2,801,453 | -81.8% | 0.01% | -83.9% |
| Q4 2014 | $118,585,000 | +4.2% | 15,380,682 | +1.0% | 0.03% | 0.0% |
| Q3 2014 | $113,797,000 | -61.3% | 15,233,836 | -49.9% | 0.03% | -22.5% |
| Q2 2014 | $294,310,000 | +124.6% | 30,403,742 | +92.8% | 0.04% | +11.1% |
| Q1 2014 | $131,021,000 | -0.2% | 15,766,856 | +1.3% | 0.04% | -2.7% |
| Q4 2013 | $131,341,000 | -46.3% | 15,561,779 | -49.3% | 0.04% | 0.0% |
| Q3 2013 | $244,598,000 | +114.7% | 30,689,734 | +108.0% | 0.04% | +2.8% |
| Q2 2013 | $113,917,000 | – | 14,756,212 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |